siRNA treatment targeting integrin alpha11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression. Chaudhary P, Yadav K, Lee HJ, Kang KW, et al. Breast Cancer Res 2024;26:72.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chaudhary P, Yadav K, Lee HJ, Kang KW, et al. siRNA treatment targeting integrin alpha11 overexpressed via EZH2-driven axis inhibits drug-resistant breast cancer progression. Breast Cancer Res 2024;26:72.
PMID: 38664825